A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Ditching Invading DNA: Bacteria and archaea protect themselves from invasive foreign nucleic acids through an RNA-mediated adaptive immune system called CRISPR (clustered regularly interspaced short palindromic repeats)/CRISPR-associated (Cas). Jinek et al. (p. 816 , published online 28 June; see the Perspective by Brouns ) found that for the type II CRISPR/Cas system, the CRISPR RNA (crRNA) as well as the trans-activating crRNA—which is known to be involved in the pre-crRNA processing—were both required to direct the Cas9 endonuclease to cleave the invading target DNA. Furthermore, engineered RNA molecules were able to program the Cas9 endonuclease to cleave specific DNA sequences to generate double-stranded DNA breaks.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Repurposing bacterial “CRISPR” systems to facilitate RNA-guided cleavage of complementary DNA has revolutionized the field of gene editing in mammalian cells 1–4.”
From A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells (2018) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“To realize this promise, the development of CRISPR-Cas9 for genome editing offers a simpler technology that has been adopted widely due to the ease of programming its DNA binding and modifying capabilities.”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recombinant expression and purification of EvoCas9–1 paired with chemically synthesized Evo-generated single guide RNA (sgRNA) exhibited comparable in vitro cleavage activity to SpCas9 paired with the canonical SpCas9 sgRNA”
From Sequence modeling and design from molecular to genome scale with Evo (2024) · cites this paper as [62]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cas9 can create DNA cleavage at desired genomic positions that are guided by precise base pairing between sgRNA and DNA, adjacent to a protospacer-adjacent motif (PAM) (Jinek et al., 2012; Cho et al., 2013; Cong et al., 2013; Wang et al., 2016a).”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Jinek et al., 2012
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CRISPR/Cas9 is a class of ribonucleoprotein complexes formed by a Cas9 protein and a single guide RNA (sgRNA) (Jinek et al., 2012; Cho et al., 2013; Cong et al., 2013; Wang et al., 2016a).”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Jinek et al., 2012
Experimental — accuracy not yet measured
31 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855
CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007) · Science · doi:10.1126/science.1138140 · Cited by 5,947
CRISPR RNA Maturation by Trans-Encoded Small RNA and Host Factor RNase III
Deltcheva, E., Chylinski, K., Sharma, C. M., Gonzales, K., Chao, Y., Pirzada, Z. A., Eckert, M. R., Vogel, J., & Charpentier, E. (2011) · Nature · doi:10.1038/nature09886 · Cited by 2,563
Self-citationSmall CRISPR RNAs Guide Antiviral Defense in Prokaryotes
Brouns, S. J. J., Jore, M. M., Lundgren, M., Westra, E. R., Slijkhuis, R. J. H., Snijders, A. P. L., Dickman, M. J., Makarova, K. S., Koonin, E. V., & van der Oost, J. (2008) · Science · doi:10.1126/science.1159689 · Cited by 2,460
Evolution and classification of the CRISPR–Cas systems
Makarova, K. S., Haft, D. H., Barrangou, R., Brouns, S. J. J., Charpentier, E., Horvath, P., Moineau, S., Mojica, F. J. M., Wolf, Y. I., Yakunin, A. F., et al. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2577 · Cited by 2,331
Self-citationThe CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA
Garneau, J. E., Dupuis, M.-È., Villion, M., Romero, D. A., Barrangou, R., Boyaval, P., Fremaux, C., Horvath, P., Magadán, A. H., & Moineau, S. (2010) · Nature · doi:10.1038/nature09523 · Cited by 2,328
Genome editing with engineered zinc finger nucleases
Urnov, F. D., Rebar, E. J., Holmes, M. C., Zhang, H. S., & Gregory, P. D. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2842 · Cited by 2,285
A TALE nuclease architecture for efficient genome editing
Miller, J. C., Tan, S., Qiao, G., Barlow, K. A., Wang, J., Xia, D. F., Meng, X., Paschon, D. E., Leung, E., Hinkley, S. J., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1755 · Cited by 2,098
Targeting DNA Double-Strand Breaks with TAL Effector Nucleases
Christian, M., Cermak, T., Doyle, E. L., Schmidt, C., Zhang, F., Hummel, A., Bogdanove, A. J., & Voytas, D. F. (2010) · Genetics · doi:10.1534/genetics.110.120717 · Cited by 1,869
Cited by
Items 801–900 of 1,285
Live cell imaging of low- and non-repetitive chromosome loci using CRISPR-Cas9
Qin, P., Parlak, M., Kuscu, C., Bandaria, J., Mir, M., Szlachta, K., Singh, R., Darzacq, X., Yildiz, A., & Adli, M. (2017) · Nature Communications · doi:10.1038/ncomms14725 · Cited by 235
Chen, W., Zhang, Y., Zhang, Y., Pi, Y., Gu, T., Song, L., Wang, Y., & Ji, Q. (2018) · iScience · doi:10.1016/j.isci.2018.07.024 · Cited by 237
Walking a tightrope: The complex balancing act of R-loops in genome stability
Brickner, J. R., Garzon, J. L., & Cimprich, K. A. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.04.014 · Cited by 239
Nucleosome breathing and remodeling constrain CRISPR-Cas9 function
Isaac, R. S., Jiang, F., Doudna, J. A., Lim, W. A., Narlikar, G. J., & Almeida, R. (2016) · eLife · doi:10.7554/elife.13450 · Cited by 234
“…tool for genome engineering, gene regulation, and live imaging is a remarkable achievement with profound impact in a wide variety of research fields and applications ( Makarova et al., 2015 ; Doudna and Charpentier, 2014 ; Cong et al., 2013 ; Jinek et al., 2012 ; 2013 ; Mali et al., 2013 ).”
Self-citationZhen, S., Hua, L., Liu, Y.-H., Gao, L.-C., Fu, J., Wan, D.-Y., Dong, L.-H., Song, H.-F., & Gao, X. (2015) · Gene Therapy · doi:10.1038/gt.2015.2 · Cited by 215
Wagner, J. M., & Alper, H. S. (2016) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2015.12.001 · Cited by 239
Zhang, J., Zong, W., Hong, W., Zhang, Z.-T., & Wang, Y. (2018) · Metabolic Engineering · doi:10.1016/j.ymben.2018.03.007 · Cited by 236
Lobo, A.-M., Agelidis, A. M., & Shukla, D. (2019) · The Ocular Surface · doi:10.1016/j.jtos.2018.10.002 · Cited by 224
Shelake, R. M., Kadam, U. S., Kumar, R., Pramanik, D., Singh, A. K., & Kim, J.-Y. (2022) · Plant Communications · doi:10.1016/j.xplc.2022.100417 · Cited by 222
“Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein (CRISPR/ Cas) is the newest addition to the GE arsenal (Jinek et al., 2012).”
A Platform for Rapid Exploration of Aging and Diseases in a Naturally Short-Lived Vertebrate
Harel, I., Benayoun, B. A., Machado, B., Singh, P. P., Hu, C.-K., Pech, M. F., Valenzano, D. R., Zhang, E., Sharp, S. C., Artandi, S. E., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.038 · Cited by 232
Robust Transcriptional Activation in Plants Using Multiplexed CRISPR-Act2.0 and mTALE-Act Systems
Lowder, L. G., Zhou, J., Zhang, Y., Malzahn, A., Zhong, Z., Hsieh, T.-F., Voytas, D. F., Zhang, Y., & Qi, Y. (2018) · Molecular Plant · doi:10.1016/j.molp.2017.11.010 · Cited by 232
The Multifaceted Biology of PCSK9
Seidah, N. G., & Prat, A. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab035 · Cited by 232
CRISPR-Cas9 for the genome engineering of cyanobacteria and succinate production
Li, H., Shen, C. R., Huang, C.-H., Sung, L.-Y., Wu, M.-Y., & Hu, Y.-C. (2016) · Metabolic Engineering · doi:10.1016/j.ymben.2016.09.006 · Cited by 233
Plant Genome Engineering for Targeted Improvement of Crop Traits
Sedeek, K. E. M., Mahas, A., & Mahfouz, M. (2019) · Frontiers in Plant Science · doi:10.3389/fpls.2019.00114 · Cited by 216
Molecular and Hormonal Mechanisms Regulating Fleshy Fruit Ripening
Li, S., Chen, K., & Grierson, D. (2021) · Cells · doi:10.3390/cells10051136 · Cited by 226
Gao, P., Yang, H., Rajashankar, K. R., Huang, Z., & Patel, D. J. (2016) · Cell Research · doi:10.1038/cr.2016.88 · Cited by 237
A bacteriophage nucleus-like compartment shields DNA from CRISPR nucleases
Mendoza, S. D., Nieweglowska, E. S., Govindarajan, S., Leon, L. M., Berry, J. D., Tiwari, A., Chaikeeratisak, V., Pogliano, J., Agard, D. A., & Bondy-Denomy, J. (2020) · Nature · doi:10.1038/s41586-019-1786-y · Cited by 247
Quantitative evaluation of chromosomal rearrangements in gene-edited human stem cells by CAST-Seq
Turchiano, G., Andrieux, G., Klermund, J., Blattner, G., Pennucci, V., el Gaz, M., Monaco, G., Poddar, S., Mussolino, C., Cornu, T. I., et al. (2021) · Cell Stem Cell · doi:10.1016/j.stem.2021.02.002 · Cited by 232
Application of CRISPR/Cas9 in Crop Quality Improvement
Liu, Q., Yang, F., Zhang, J., Liu, H., Rahman, S., Islam, S., Ma, W., & She, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084206 · Cited by 216
“Under the guidance of gRNA, Cas9 nuclease creates DSBs at ~3 bp upstream of the PAM motif [21].”
BackgroundCRISPR/Cas-mediated plant genome editing: outstanding challenges a decade after implementation
Cardi, T., Murovec, J., Bakhsh, A., Boniecka, J., Bruegmann, T., Bull, S. E., Eeckhaut, T., Fladung, M., Galovic, V., Linkiewicz, A., et al. (2023) · Trends in Plant Science · doi:10.1016/j.tplants.2023.05.012 · Cited by 213
“In the fi rst decade of use, CRISPR/Cas technology exceeded initial expectations by providing a precise, easy to implement, and high-throughput tool for targeted genetic modi fi cations to plant research and breeding activities [151].”
MethodEfficient gene editing in Neurospora crassa with CRISPR technology
Matsu-ura, T., Baek, M., Kwon, J., & Hong, C. (2015) · Fungal Biology and Biotechnology · doi:10.1186/s40694-015-0015-1 · Cited by 233
The New State of the Art: Cas9 for Gene Activation and Repression
La Russa, M. F., & Qi, L. S. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00512-15 · Cited by 229
“Cas9’s two nuclease domains, the RuvC and HNH domains, are conserved among several types of nucleases, and each is responsible for cutting one strand of DNA upon binding (3, 4, 19).”
BackgroundPrecise in-frame integration of exogenous DNA mediated by CRISPR/Cas9 system in zebrafish
Hisano, Y., Sakuma, T., Nakade, S., Ohga, R., Ota, S., Okamoto, H., Yamamoto, T., & Kawahara, A. (2015) · Scientific Reports · doi:10.1038/srep08841 · Cited by 231
CRISPR-Cas9 and CRISPR-Cpf1 mediated targeting of a stomatal developmental gene EPFL9 in rice
Yin, X., Biswal, A. K., Dionora, J., Perdigon, K. M., Balahadia, C. P., Mazumdar, S., Chater, C., Lin, H.-C., Coe, R. A., Kretzschmar, T., et al. (2017) · Plant Cell Reports · doi:10.1007/s00299-017-2118-z · Cited by 228
Lignin-based polymers and nanomaterials
Grossman, A., & Vermerris, W. (2019) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2018.10.009 · Cited by 228
Use of designer nucleases for targeted gene and genome editing in plants
Weeks, D. P., Spalding, M. H., & Yang, B. (2016) · Plant Biotechnology Journal · doi:10.1111/pbi.12448 · Cited by 227
CRISPR base editors: genome editing without double-stranded breaks
Eid, A., Alshareef, S., & Mahfouz, M. M. (2018) · Biochemical Journal · doi:10.1042/bcj20170793 · Cited by 224
Direct observation of DNA target searching and cleavage by CRISPR-Cas12a
Jeon, Y., Choi, Y. H., Jang, Y., Yu, J., Goo, J., Lee, G., Jeong, Y. K., Lee, S. H., Kim, I.-S., Kim, J.-S., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05245-x · Cited by 239
Selection of highly efficient sgRNAs for CRISPR/Cas9-based plant genome editing
Liang, G., Zhang, H., Lou, D., & Yu, D. (2016) · Scientific Reports · doi:10.1038/srep21451 · Cited by 231
CRISPR-Cpf1 correction of muscular dystrophy mutations in human cardiomyocytes and mice
Zhang, Y., Long, C., Li, H., McAnally, J. R., Baskin, K. K., Shelton, J. M., Bassel-Duby, R., & Olson, E. N. (2017) · Science Advances · doi:10.1126/sciadv.1602814 · Cited by 231
Harrison, M. M., Jenkins, B. V., O’Connor-Giles, K. M., & Wildonger, J. (2014) · Genes & Development · doi:10.1101/gad.248252.114 · Cited by 226
“This three-component system was simplified by fusing together crRNA and tracrRNA, creating a single chimeric ‘‘guide’’ RNA (abbreviated as sgRNA or simply gRNA) (Gasiunas et al. 2012; Jinek et al. 2012).”
BackgroundMethodInfluentialIn vitro reconstitution of Cascade‐mediated CRISPR immunity in Streptococcus thermophilus
Sinkunas, T., Gasiunas, G., Waghmare, S. P., Dickman, M. J., Barrangou, R., Horvath, P., & Siksnys, V. (2013) · The EMBO Journal · doi:10.1038/emboj.2012.352 · Cited by 228
“…immunity solely relies on the signature Cas9 protein that associates with crRNA to form an effector complex, which specifically cleaves matching target double-stranded DNA (dsDNA) (Garneau et al , 2010; Deltcheva et al , 2011; Sapranauskas et al , 2011; Gasiunas et al , 2012; Jinek et al , 2012).”
Principles, Applications, and Biosafety of Plant Genome Editing Using CRISPR-Cas9
El-Mounadi, K., Morales-Floriano, M. L., & Garcia-Ruiz, H. (2020) · Frontiers in Plant Science · doi:10.3389/fpls.2020.00056 · Cited by 219
“processed to form one or several short guide RNAs that direct Cas9 to the target DNA sequence (Figure 1) (Jinek et al., 2012; Lander, 2016; Jiang and Doudna, 2017).”
BackgroundCRISPR‐Cas systems and RNA‐guided interference
Barrangou, R. (2013) · WIREs RNA · doi:10.1002/wrna.1159 · Cited by 227
A scalable strategy for high-throughput GFP tagging of endogenous human proteins
Leonetti, M. D., Sekine, S., Kamiyama, D., Weissman, J. S., & Huang, B. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1606731113 · Cited by 237
“Cas9 protein can be readily purified from Escherichia coli overexpression cultures (22).”
BackgroundApplication of CRISPR/Cas9 in plant biology
Liu, X., Wu, S., Xu, J., Sui, C., & Wei, J. (2017) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2017.01.002 · Cited by 222
“Jinek et al.(16) demonstrated that a single guide RNA (sgRNA) formed by fusing crRNA to tracrRNA plays the same role as a crRNA-tracrRNA hybrid.”
BackgroundFunctional Genetic Variants Revealed by Massively Parallel Precise Genome Editing
Sharon, E., Chen, S.-A. A., Khosla, N. M., Smith, J. D., Pritchard, J. K., & Fraser, H. B. (2018) · Cell · doi:10.1016/j.cell.2018.08.057 · Cited by 225
“Indeed, CRISPR/Cas9 has recently transformed our ability to characterize individual genetic variants via genome editing (Cong et al., 2013; DiCarlo et al., 2013; Jinek et al., 2012; Mali et al., 2013).”
BackgroundJensen, K. T., Fløe, L., Petersen, T. S., Huang, J., Xu, F., Bolund, L., Luo, Y., & Lin, L. (2017) · FEBS Letters · doi:10.1002/1873-3468.12707 · Cited by 225
Genetic engineering of microalgae for enhanced biorefinery capabilities
Fayyaz, M., Chew, K. W., Show, P. L., Ling, T. C., Ng, I.-S., & Chang, J.-S. (2020) · Biotechnology Advances · doi:10.1016/j.biotechadv.2020.107554 · Cited by 225
Guo, M., Ruan, W., Li, C., Huang, F., Zeng, M., Liu, Y., Yu, Y., Ding, X., Wu, Y., Wu, Z., et al. (2015) · Plant Physiology · doi:10.1104/pp.15.00736 · Cited by 227
“444 The CRISPR (clusters of regularly interspaced short palindromic repeats)/Cas9 445 endonuclease system is a site-specific genomic editing tool used in many organisms (Hale et al., 446 2009; Jore et al., 2011; Carroll, 2012; Jinek et al., 2012), including plants (Feng et al.”
MethodCRMAGE: CRISPR Optimized MAGE Recombineering
Ronda, C., Pedersen, L. E., Sommer, M. O. A., & Nielsen, A. T. (2016) · Scientific Reports · doi:10.1038/srep19452 · Cited by 224
Sugano, S. S., Nishihama, R., Shirakawa, M., Takagi, J., Matsuda, Y., Ishida, S., Shimada, T., Hara-Nishimura, I., Osakabe, K., & Kohchi, T. (2018) · PLOS ONE · doi:10.1371/journal.pone.0205117 · Cited by 237
Retinal stem cell transplantation: Balancing safety and potential
Singh, M. S., Park, S. S., Albini, T. A., Canto-Soler, M. V., Klassen, H., MacLaren, R. E., Takahashi, M., Nagiel, A., Schwartz, S. D., & Bharti, K. (2020) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2019.100779 · Cited by 225
“The advent of CRISPR gene editing technology (Jinek et al., 2012; Mali et al., 2013) may provide avenues to correct genetic mutations in self-derived stem cells (Burnight et al.”
Treatment of a Mouse Model of ALS by In Vivo Base Editing
Lim, C. K. W., Gapinske, M., Brooks, A. K., Woods, W. S., Powell, J. E., Zeballos C., M. A., Winter, J., Perez-Pinera, P., & Gaj, T. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.01.005 · Cited by 222
“Genome-editing technologies, including RNA-guided CRISPR-Cas9 nucleases, 25 – 28 offer an alternative approach for treating ALS by providing a means to permanently disable the function of the mutant SOD1 gene.”
BackgroundSchneider, N., Sundaresan, Y., Gopalakrishnan, P., Beryozkin, A., Hanany, M., Levanon, E. Y., Banin, E., Ben-Aroya, S., & Sharon, D. (2022) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.101029 · Cited by 224
Transcription in Living Cells: Molecular Mechanisms of Bursting
Rodriguez, J., & Larson, D. R. (2020) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-011520-105250 · Cited by 224
“Repeats of this stem-loop are inserted into a gene of interest using clustered regularly interspaced short palindromic repeat–CRISPR associated protein 9 (CRISPR-Cas9)-directed homologous repair (22).”
BackgroundStructure of the Cpf1 endonuclease R-loop complex after target DNA cleavage
Stella, S., Alcón, P., & Montoya, G. (2017) · Nature · doi:10.1038/nature22398 · Cited by 244
CRISPR/Cas9-coupled recombineering for metabolic engineering of Corynebacterium glutamicum
Cho, J. S., Choi, K. R., Prabowo, C. P. S., Shin, J. H., Yang, D., Jang, J., & Lee, S. Y. (2017) · Metabolic Engineering · doi:10.1016/j.ymben.2017.06.010 · Cited by 228
CRISPR–Cas9: A History of Its Discovery and Ethical Considerations of Its Use in Genome Editing
Gostimskaya, I. (2022) · Biochemistry (Moscow) · doi:10.1134/s0006297922080090 · Cited by 224
“One of the first patent applications was filed jointly by the University of California at Berkeley, representing Doudna, the University of Vienna (where one of the two lead authors from the key publication on CRISPR–Cas9 worked [33]), and Charpentier as an individual inventor in accordance with the rules of the Univer…”
BackgroundMethodCardiovascular disease models: A game changing paradigm in drug discovery and screening
Savoji, H., Mohammadi, M. H., Rafatian, N., Toroghi, M. K., Wang, E. Y., Zhao, Y., Korolj, A., Ahadian, S., & Radisic, M. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.09.036 · Cited by 223
Genome editing in Ustilago maydis using the CRISPR–Cas system
Schuster, M., Schweizer, G., Reissmann, S., & Kahmann, R. (2016) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2015.09.001 · Cited by 225
Efficient Genome Editing in Clostridium cellulolyticum via CRISPR-Cas9 Nickase
Xu, T., Li, Y., Shi, Z., Hemme, C. L., Li, Y., Zhu, Y., Van Nostrand, J. D., He, Z., & Zhou, J. (2015) · Applied and Environmental Microbiology · doi:10.1128/aem.00873-15 · Cited by 223
“S1A in the supplemental material), where N represents any nucleotide and N20 represents the protospacer appended with a protospaceradjacent motif (PAM) (NGG) at the 3= end (8).”
BackgroundMethodVarshney, G. K., Carrington, B., Pei, W., Bishop, K., Chen, Z., Fan, C., Xu, L., Jones, M., LaFave, M. C., Ledin, J., et al. (2016) · Nature Protocols · doi:10.1038/nprot.2016.141 · Cited by 228
Minimal PAM specificity of a highly similar SpCas9 ortholog
Chatterjee, P., Jakimo, N., & Jacobson, J. M. (2018) · Science Advances · doi:10.1126/sciadv.aau0766 · Cited by 228
“INTRODUCTION RNA-guided endonucleases of the CRISPR-Cas system, such as Cas9 (1) and Cpf1 (also known as Cas12a) (2), have proven to be versatile tools for genome editing and regulation (3), which have numerous implications in medicine, agriculture, bioenergy, food security, nanotechnology, and beyond (4).”
BackgroundCRISPR-Cas-Based Antimicrobials: Design, Challenges, and Bacterial Mechanisms of Resistance
Mayorga-Ramos, A., Zúñiga-Miranda, J., Carrera-Pacheco, S. E., Barba-Ostria, C., & Guamán, L. P. (2023) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.2c00649 · Cited by 207
CRISPR RNAs Trigger Innate Immune Responses in Human Cells
Kim, S., Koo, T., Jee, H.-G., Cho, H.-Y., Lee, G., Lim, D.-G., Shin, H. S., & Kim, J.-S. (2018) · Genome Research · doi:10.1101/gr.231936.117 · Cited by 222
CRISPR-Based Adenine Editors Correct Nonsense Mutations in a Cystic Fibrosis Organoid Biobank
Geurts, M. H., de Poel, E., Amatngalim, G. D., Oka, R., Meijers, F. M., Kruisselbrink, E., van Mourik, P., Berkers, G., de Winter-de Groot, K. M., Michel, S., et al. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.01.019 · Cited by 222
Targeted mutagenesis using CRISPR/Cas system in medaka
Ansai, S., & Kinoshita, M. (2014) · Biology Open · doi:10.1242/bio.20148177 · Cited by 227
“…one being the base-pair complementarity between the first 20 nucleotides (nts) of a guide RNA and a target DNA sequence, and the other being the sequence ‘‘NGG’’, referred to as the protospacer adjacent motif (PAM), adjacent to the complementary region in the target site (Jinek et al., 2012).”
BackgroundInfluentialRapid characterization of CRISPR-Cas9 protospacer adjacent motif sequence elements
Karvelis, T., Gasiunas, G., Young, J., Bigelyte, G., Silanskas, A., Cigan, M., & Siksnys, V. (2015) · Genome Biology · doi:10.1186/s13059-015-0818-7 · Cited by 225
“4d) similar to that observed for Spy, Sth3, and Sth1 Cas9 proteins [6, 7, 22].”
BackgroundMethodInfluentialLau, E. S.-W., Zhang, Z., Qin, M., & Ge, W. (2016) · Scientific Reports · doi:10.1038/srep37357 · Cited by 222
Kao, P.-H., & Ng, I.-S. (2017) · Bioresource Technology · doi:10.1016/j.biortech.2017.04.111 · Cited by 221
EasyCloneYALI: CRISPR/Cas9‐Based Synthetic Toolbox for Engineering of the Yeast Yarrowia lipolytica
Holkenbrink, C., Dam, M. I., Kildegaard, K. R., Beder, J., Dahlin, J., Doménech Belda, D., & Borodina, I. (2018) · Biotechnology Journal · doi:10.1002/biot.201700543 · Cited by 223
Potential of Genome Editing to Improve Aquaculture Breeding and Production
Gratacap, R. L., Wargelius, A., Edvardsen, R. B., & Houston, R. D. (2019) · Trends in Genetics · doi:10.1016/j.tig.2019.06.006 · Cited by 221
Generation of a multiplex mutagenesis population via pooled CRISPR‐Cas9 in soya bean
Bai, M., Yuan, J., Kuang, H., Gong, P., Li, S., Zhang, Z., Liu, B., Sun, J., Yang, M., Yang, L., et al. (2020) · Plant Biotechnology Journal · doi:10.1111/pbi.13239 · Cited by 222
“Such challenges can be countered, at least in part, by the clustered regularly interspaced short palindromic repeat (CRISPR)associated protein (Cas9) (CRISPR-Cas9) system (Cong et al., 2013; Jinek et al., 2012; Li et al., 2015).”
BackgroundZaidi, S. S.-E.-A., Mahas, A., Vanderschuren, H., & Mahfouz, M. M. (2020) · Genome Biology · doi:10.1186/s13059-020-02204-y · Cited by 221
Synthetic CRISPR-Cas gene activators for transcriptional reprogramming in bacteria
Dong, C., Fontana, J., Patel, A., Carothers, J. M., & Zalatan, J. G. (2018) · Nature Communications · doi:10.1038/s41467-018-04901-6 · Cited by 224
Animal models of arrhythmia: classic electrophysiology to genetically modified large animals
Clauss, S., Bleyer, C., Schüttler, D., Tomsits, P., Renner, S., Klymiuk, N., Wakili, R., Massberg, S., Wolf, E., & Kääb, S. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0179-0 · Cited by 216
RNA-guided endonuclease provides a therapeutic strategy to cure latent herpesviridae infection
Wang, J., & Quake, S. R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1410785111 · Cited by 220
Jasin, M., & Haber, J. E. (2016) · DNA Repair · doi:10.1016/j.dnarep.2016.05.001 · Cited by 223
“recognition, making it an ideal programmable nuclease, but with the twist of relying on RNA:DNA rather than DNA:DNA recognition [153, 154].”
BackgroundCRISPR-based rapid and ultra-sensitive diagnostic test for Mycobacterium tuberculosis
Ai, J.-W., Zhou, X., Xu, T., Yang, M., Chen, Y., He, G.-Q., Pan, N., Cai, Y., Li, Y., Wang, X., et al. (2019) · Emerging Microbes & Infections · doi:10.1080/22221751.2019.1664939 · Cited by 220
“strated to confer great sensitivity[6].”
Cellular and Neural Responses to Sour Stimuli Require the Proton Channel Otop1
Teng, B., Wilson, C. E., Tu, Y.-H., Joshi, N. R., Kinnamon, S. C., & Liman, E. R. (2019) · Current Biology · doi:10.1016/j.cub.2019.08.077 · Cited by 223
“To definitively establish the necessity of Otop1 for proton currents in TRCs and test contributions of the channel to taste signaling in vivo, we used CRISPR/Cas 9 gene editing [37, 38] to engineer PKD2L1-YFP mice lacking a functional Otop1 gene.”
Paving the Road for RNA Therapeutics
Dammes, N., & Peer, D. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.08.004 · Cited by 218
“To simplify the tool, these two RNAs are combined on a single guide RNA chimera (sgRNA) [41].”
In vivo delivery of CRISPR-Cas9 therapeutics: Progress and challenges
Behr, M., Zhou, J., Xu, B., & Zhang, H. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.05.020 · Cited by 210
Biological plasticity rescues target activity in CRISPR knock outs
Smits, A. H., Ziebell, F., Joberty, G., Zinn, N., Mueller, W. F., Clauder-Münster, S., Eberhard, D., Fälth Savitski, M., Grandi, P., Jakob, P., et al. (2019) · Nature Methods · doi:10.1038/s41592-019-0614-5 · Cited by 219
A genome-wide analysis of Cas9 binding specificity using ChIP-seq and targeted sequence capture
O'Geen, H., Henry, I. M., Bhakta, M. S., Meckler, J. F., & Segal, D. J. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv137 · Cited by 219
“GC-skewed R-loop-prone regions are highly enriched in CpG islands, 5’-UTRs and DNaseI accessible regions which are features associated with off-target binding sites in this study (Figure 2) and by another group (Wu et al. 2014).”
BackgroundMethodInfluentialAdvances in Industrial Biotechnology Using CRISPR-Cas Systems
Donohoue, P. D., Barrangou, R., & May, A. P. (2018) · Trends in Biotechnology · doi:10.1016/j.tibtech.2017.07.007 · Cited by 218
“The Type II system is characterized by its signature single effector protein Cas9 [22,32], and has seen the broadest adoption for programmable targeting in worms [33], flies [34], plants [35], mammals [36–39], and other eukaryotes, including industrially relevant species of yeast [40] and filamentous fungi [41].”
BackgroundEsposito, R., Bosch, N., Lanzós, A., Polidori, T., Pulido-Quetglas, C., & Johnson, R. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.01.019 · Cited by 219
Edvardsen, R. B., Leininger, S., Kleppe, L., Skaftnesmo, K. O., & Wargelius, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108622 · Cited by 217
“A construct which has been tailored for targeted mutations is a fusion of crRNA and tracrRNA functioning as a guide RNA (gRNA) which in combination with the Cas9 nuclease can then induce double DNA strand breaks [21].”
BackgroundCRISPR/Cas9 advances engineering of microbial cell factories
Jakočiūnas, T., Jensen, M. K., & Keasling, J. D. (2016) · Metabolic Engineering · doi:10.1016/j.ymben.2015.12.003 · Cited by 219
Cas9-chromatin binding information enables more accurate CRISPR off-target prediction
Singh, R., Kuscu, C., Quinlan, A., Qi, Y., & Adli, M. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv575 · Cited by 217
A CRISPR-Based Screen Identifies Genes Essential for West-Nile-Virus-Induced Cell Death
Ma, H., Dang, Y., Wu, Y., Jia, G., Anaya, E., Zhang, J., Abraham, S., Choi, J.-G., Shi, G., Qi, L., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.06.049 · Cited by 223
“…easy knockout of both alleles in a substantial percentage of treated cells (Chang et al., 2013; Cho et al., 2013; Cong et al., 2013; Dicarlo et al., 2013; Gasiunas et al., 2012; Hwang et al., 2013; Jiang et al., 2013; Jinek et al., 2012; Jinek et al., 2013; Mali et al., 2013; Qi et al., 2013).”
BackgroundMao, Y., Zhang, Z., Feng, Z., Wei, P., Zhang, H., Botella, J. R., & Zhu, J. (2016) · Plant Biotechnology Journal · doi:10.1111/pbi.12468 · Cited by 219
“Engineered endonuclease technologies offer a promising alternative to perform targeted gene mutation and other modifications in many species (Joung and Sander, 2012; Kim and Kim, 2014; Urnov et al., 2010).”
Structure and Activity of the RNA-Targeting Type III-B CRISPR-Cas Complex of Thermus thermophilus
Staals, R. H. J., Agari, Y., Maki-Yonekura, S., Zhu, Y., Taylor, D. W., van Duijn, E., Barendregt, A., Vlot, M., Koehorst, J. J., Sakamoto, K., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.09.013 · Cited by 218
Self-citationWolter, F., Schindele, P., & Puchta, H. (2019) · BMC Plant Biology · doi:10.1186/s12870-019-1775-1 · Cited by 214
Bier, E. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-021-00386-0 · Cited by 219
Westra, E. R., Semenova, E., Datsenko, K. A., Jackson, R. N., Wiedenheft, B., Severinov, K., & Brouns, S. J. J. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003742 · Cited by 218
CRISPR-Cas9 Can Inhibit HIV-1 Replication but NHEJ Repair Facilitates Virus Escape
Wang, G., Zhao, N., Berkhout, B., & Das, A. T. (2016) · Molecular Therapy · doi:10.1038/mt.2016.24 · Cited by 215
Cao, J., Wu, L., Zhang, S.-M., Lu, M., Cheung, W. K. C., Cai, W., Gale, M., Xu, Q., & Yan, Q. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw660 · Cited by 217
Black, J. B., Adler, A. F., Wang, H.-G., D’Ippolito, A. M., Hutchinson, H. A., Reddy, T. E., Pitt, G. S., Leong, K. W., & Gersbach, C. A. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.07.001 · Cited by 219
“…Cas9 nuclease have recently been repurposed from an adaptive immune system in bacteria and archaea to a gene editing tool (Cong et al., 2013; Jinek et al., 2012; Mali et al., 2013b) and transcriptional regulator (Cheng et al., 2013; Gilbert et al., 2013; Konermann et al., 2013; Maeder et…”
CtIP fusion to Cas9 enhances transgene integration by homology-dependent repair
Charpentier, M., Khedher, A. H. Y., Menoret, S., Brion, A., Lamribet, K., Dardillac, E., Boix, C., Perrouault, L., Tesson, L., Geny, S., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03475-7 · Cited by 214
Chen, W., McKenna, A., Schreiber, J., Haeussler, M., Yin, Y., Agarwal, V., Noble, W. S., & Shendure, J. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz487 · Cited by 216
Discovery of a molecular glue promoting CDK12-DDB1 interaction to trigger cyclin K degradation
Lv, L., Chen, P., Cao, L., Li, Y., Zeng, Z., Cui, Y., Wu, Q., Li, J., Wang, J.-H., Dong, M.-Q., et al. (2020) · eLife · doi:10.7554/elife.59994 · Cited by 215
Nishiyama, J., Mikuni, T., & Yasuda, R. (2017) · Neuron · doi:10.1016/j.neuron.2017.10.004 · Cited by 215
Harnessing Type I and Type III CRISPR-Cas systems for genome editing
Li, Y., Pan, S., Zhang, Y., Ren, M., Feng, M., Peng, N., Chen, L., Liang, Y. X., & She, Q. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1044 · Cited by 224
“Immediately after the discovery, this simplicity has been explored for genome editing in higher eukaryotes at cellular (10) and organismal levels (12), and the past few years have witnessed an explosion of application of this technology in the globe such that CRISPR-Cas9 technology has currently been applied in many d…”
BackgroundThe Discovery, Mechanisms, and Evolutionary Impact of Anti-CRISPRs
Borges, A. L., Davidson, A. R., & Bondy-Denomy, J. (2017) · Annual Review of Virology · doi:10.1146/annurev-virology-101416-041616 · Cited by 220
Aptazyme-embedded guide RNAs enable ligand-responsive genome editing and transcriptional activation
Tang, W., Hu, J. H., & Liu, D. R. (2017) · Nature Communications · doi:10.1038/ncomms15939 · Cited by 218
Editing of an Alpha-Kafirin Gene Family Increases, Digestibility and Protein Quality in Sorghum
Li, A., Jia, S., Yobi, A., Ge, Z., Sato, S. J., Zhang, C., Angelovici, R., Clemente, T. E., & Holding, D. R. (2018) · Plant Physiology · doi:10.1104/pp.18.00200 · Cited by 214
CRISPR-Mediated Programmable 3D Genome Positioning and Nuclear Organization
Wang, H., Xu, X., Nguyen, C. M., Liu, Y., Gao, Y., Lin, X., Daley, T., Kipniss, N. H., La Russa, M., & Qi, L. S. (2018) · Cell · doi:10.1016/j.cell.2018.09.013 · Cited by 215
“editing, chromatin looping, and live-cell genome imaging (Barrangou et al., 2007; Chen et al., 2013; Cong et al., 2013; Hilton et al., 2015; Jinek et al., 2012; Mali et al., 2013; Morgan et al., 2017; Qi et al., 2013).”
Assessing and advancing the safety of CRISPR-Cas tools: from DNA to RNA editing
Tao, J., Bauer, D. E., & Chiarle, R. (2023) · Nature Communications · doi:10.1038/s41467-023-35886-6 · Cited by 207
Viral Vector-Based Gene Therapy
Li, X., Le, Y., Zhang, Z., Nian, X., Liu, B., & Yang, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097736 · Cited by 200
Metadata
- Authors
- Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E.
- Affiliations
- Howard Hughes Medical Institute (HHMI), University of California, Berkeley, CA 94720, USA.
- University of Vienna (AT)
- Umeå Centre for Microbial Research (SE)
- University of California, Berkeley (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Chylinski, Krzysztof
- Doudna, Jennifer A.
- Charpentier, Emmanuelle
- Venue
- Science
- Published
- 2012-08-17
- Volume
- 337
- Issue
- 6096
- Pages
- 816-821
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC6286148
- OpenAlex
- W2045435533
- Semantic Scholar
- 68d962effe5520777791bd6ec8ffa4b963ba4f38
- Cited by
- 17,116
- References
- 48
- Citations by year
- 2026: 1083 · 2025: 1512 · 2024: 1602 · 2023: 1572 · 2022: 1795 · 2021: 1793 · 2020: 1577 · 2019: 1344 · 2018: 1255 · 2017: 1141 · 2016: 1018 · 2015: 680 · 2014: 467 · 2013: 231 · 2012: 29
- FWCI
- 180.75
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- CRISPR/Cas9, sequence-specific DNA cleavage, DNA double-strand breaks
- MeSH terms
- Bacteriophages, Base Sequence, Molecular Sequence Data, Nucleic Acid Conformation, Plasmids, RNA, Streptococcus pyogenes, Deoxyribonucleases, Type II Site-Specific, DNA Cleavage, DNA Breaks, Double-Stranded, Inverted Repeat Sequences
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.